Manmeet Ahluwalia

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Apollomics
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Prelude
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Janssen
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Tocagen
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Voyager Therapeutics
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Viewray
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Caris Lifesciences
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pyramid Biosciences
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Varian Medical Systems
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Cairn Therapeutics
    Date added:
    08/08/2023
    Date updated:
    08/08/2023

Pages

Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond